Kamalika Roy, M.D., M.C.R. (She/her)

  • Associate Professor of Psychiatry, School of Medicine
  • Program Director, Consultation-Liaison Psychiatry Fellowship, Psychiatry, School of Medicine
  • Thread Director, Health Equity, Diversity, and Structural Comptency, Anesthesiology and Perioperative Medicine, School of Medicine
  • OHSU Knight Cancer Institute, School of Medicine

Biography

Dr. Roy is a psycho-oncologist and a passionate advocate for women and underrepresented physicians in organized medicine. She leads the Psycho-oncology program at Knight Cancer Institute and serves as the Program Director of the Consultation-Liaison Psychiatry Fellowship at OHSU. She is board-certified in Psychiatry and Consultation-Liaison Psychiatry and the Thread Director of the Health Equity, Diversity, and Structural Competence (HEDSC) thread of the OHSU medical school curriculum.  

Her clinical interests include cognitive impacts of immune checkpoint inhibitors, distress and mood disorders in cancer, and the metabolic and inflammatory intersection between psychiatric disorders and other medical diseases. She was a leader of the American Psychiatric Association's presidential workgroup on lifestyle psychiatry, which published a practical guide on incorporating evidence-informed lifestyle measures into day-to-day psychiatric practice. 

Dr. Roy has been actively involved in organized medicine since her residency training. She is a Fellow of the American Psychiatric Association (APA) and the Academy of Consultation-Liaison Psychiatry (ACLP).  She serves on the APA board and as an alternate delegate to the Academic Physicians section of the American Medical Association (AMA). Dr. Roy has served as a Faculty Senator at Oregon Health & Science University. She also served as the faculty liaison to the Diversity, Equity, and Inclusion Subcommittee, reporting to the Undergraduate Medical Education Committee at OHSU.
 

Education and training

  • Degrees

    • M.B.B.S., North Bengal Medical College
    • M.C.R., 2020, Oregon Health & Science University
  • Residency

    • MD, Wayne State University, Detroit, Michigan, 2016
  • Fellowship

    • Consultation-liaison Psychiatry, University of Michigan, Ann Arbor, Michigan, 2017
  • Certifications

    • American Board of Psychiatry and Neurology, 2016
    • American Board of Psychiatry and Neurology, Consultation-Liaison Psychiatry, 2017

Memberships and associations:

  • American Medical Association
  • American Psychiatric Association
  • Academy of Consultation-liaison Psychiatry
  • Oregon Psychiatric Physicians Association

Areas of interest

  • Psycho-oncology
  • Palliative Psychiatry
  • Sleep Disorders
  • Cancer related cognitive impairment
  • Delirium
  • Metabolic disorders and psychiatry

Honors and awards

  • Early Career Research Mentee Award, Academy of Consultation Liaison Psychiatry (2020)
  • Fellow Award, Academy of Physicians in Clinical Research 2021
  • Fellow of American Psychiatric Association (2019)
  • Distinguished Award for Excellence in Medical Student Education, Oregon Health& Science University (2018)
  • Trainee Travel Award, Academy of Consultation-liaison Psychiatry (2015)
  • Research Award, American Psychiatric Association (2014)
  • Fellow of Academy of Consultation-liaison Psychiatry

Publications

Elsevier pure profile

Selected publications

  • Sinha A, Smolik TJ, Roy K, Bollu PC. Neuropsychiatric Manifestations of Autoimmune Encephalitis in a Tertiary Hospital A Case Series and Current Perspectives. J Clin Psychiatry. 2022 Feb 15;83
  • Wilson J.E., Andrews P., Ainsworth A., Roy K., Ely E.W. and Oldham M.A., 2021. Pseudodelirium: Psychiatric Conditions to Consider on the Differential for Delirium. The Journal of Neuropsychiatry and Clinical Neurosciences, pp.appi-neuropsych
  • Roy K, Balon R, Penumetcha V. Persistent Psychosis in Treated Neurosyphilis: When is it Time to Stop Medication? Current psychiatry, 2016 August;15(8):50-52,57-59
  • Roy K., Solenkova, N. & Mehta, P. A Wasted Opportunity During a Pandemic: The Foreign Medical Graduates in the USA. J Immigrant Minority Health 2021. https://doi.org/10.1007/s10903-021-01243-2
  • Shad MU, Felzien E, Roy K, Sethi S. How to identify and manage non-response to clozapine? Asian J Psychiatr. 2019; 45:50-52
  • Roy K, Warnick SJ, R Balon. Catatonia-delirium: Three cases treated with memantine. Psychosomatics 2016; 57(6): 645-650
  • Roy K, Balon R, Penumetcha V, Levine BH. Psychosis and Seizure Disorder: Challenges in Diagnosis and Treatment, Current Psychiatry Reports 2014; 16(11):50
  • Roy K, Balon R, Penumetcha V. Persistent Psychosis in Treated Neurosyphilis: When is it Time to Stop Medication? Current psychiatry, 2016 August;15(8):50-52,57-59
  • Merlo G (Workgroup Chair), Porter-Stransky KA, Sugden SG, et al. American Psychiatric Association Lifestyle Psychiatry Presidential Workgroup Report. Am J Psychiatry. 2025;182(9):885-887.

Publications